CF-301-105 Study Site — Salt Lake City, Utah

CF-301-105 Study Site is a clinical research site located in Salt Lake City, Utah, United States 84108.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

CF-301-105 Study Site has participated in 1 clinical trials.

Therapeutic areas: Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis.

Sponsors: ContraFect.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CF-301-105 Study Site?

CF-301-105 Study Site has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CF-301-105 Study Site conducted?

CF-301-105 Study Site has 1 clinical trials on record. Their work covers Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Endocarditis.

Is CF-301-105 Study Site accredited by Crixeo Health?

CF-301-105 Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CF-301-105 Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.